Dec 2, 2020 8:18 AM
BACK TO TOP
KSE100
41,665.27
0.00
(0.00%)
ALLSHR
29,204.74
0.00
(0.00%)
KSE30
17,533.49
0.00
(0.00%)
KMI30
67,147.45
0.00
(0.00%)
BKTi
12,698.53
0.00
(0.00%)
OGTi
13,181.41
0.00
(0.00%)
KMIALLSHR
20,551.88
0.00
(0.00%)
UPP9
11,824.68
0.00
(0.00%)
NITPGI
8,977.42
0.00
(0.00%)
NBPPGI
10,293.14
0.00
(0.00%)
MZNPI
9,942.87
0.00
(0.00%)
Sanofi-Aventis Pakistan Limited
PHARMACEUTICALS
Rs.830.00
3.50
(0.42%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Tue, Dec 1, 2020 3:34 PM
REG
FUT
ODL
Open
830.00
High
830.00
Low
830.00
Volume
50
CIRCUIT BREAKER
767.75 — 892.25
DAY RANGE
830.00 — 830.00
52-WEEK RANGE
620.00 — 1,095.57
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
830.00
VAR
20.50
HAIRCUT
27.50
P/E Ratio (TTM)
40.10
1-Year Change *
7.79%
YTD Change *
3.74%
Open
850.00
High
899.99
Low
850.00
Close
850.00
Change
2.84%
LDCP
0.00
Volume
47
Total Trades
11
CIRCUIT BREAKER
747.00 — 913.00
DAY RANGE
850.00 — 899.99
Ask Price
895.00
Ask Volume
20
Bid Price
850.00
Bid Volume
8
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Sanofi-aventis Pakistan Limited was incorporated in Pakistan in 1967 as a Public Limited Company. The Company is a subsidiary of Sanofi Foreign Participations B.V., registered in Netherlands (the Parent Company). The Ultimate Parent of the Company is Sanofi S.A., France. It is engaged in the manufacturing and selling of pharmaceutical, consumer healthcare products and vaccines.

KEY PEOPLE
Mr.Syed Babar AliChairperson
Mr.Asim JamalCEO
Mr.Muhammad YousafCompany Secretary
ADDRESS

Plot No 23, Sector 22 Korangi Industrial Area Karachi, Pakistan.

WEBSITE

www.sanofi.com.pk

REGISTRAR

FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
8,005,184.00
Shares
9,644,800
Free Float
1,446,714
Free Float
15.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2020Transmission of Financial Statements for Period Ended September 30, 2020 View   PDF
Oct 29, 2020Transmission of Financial Statements for Period Ended September 30, 2019
REVOKED
View   PDF
Oct 27, 2020Financial Results for the Period Ended September 30, 2020 View   PDF
Aug 28, 2020SAPL | Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2020 Financial Statements | PDF
Aug 26, 2020Financial Results for the Six Months Ended June 30, 2020 View   PDF
Apr 30, 2020Transmission of Quarterly Accounts for the Period Ended March 31, 2020 View   PDF
Apr 29, 2020Financial Results for the Quarter Ended March 31, 2020 View   PDF
Apr 28, 2020Transmission of Annual Report for the Year Ended December 31, 2019 View   PDF
Mar 3, 2020Financial Results for the Year Ended December 31, 2019 View   PDF
Oct 28, 2019Financial Results for the Quarter Ended September 30, 2019 View   PDF
DateTitleDocument
Oct 16, 2020Board Meeting for the Period Ended September 30, 2020 View   PDF
Aug 17, 2020BOARD MEETING FOR THE HALF YEAR ENDED JUNE 30, 2020 View   PDF
May 20, 2020Certified Abstract of Resolutions Passed at the 52nd Annual General Meeting View   PDF
Apr 28, 2020Board Meeting in Progress View   PDF
Apr 27, 2020Notice of Annual General Meeting for the Year Ended December 31, 2019 View   PDF
Apr 20, 2020Board Meeting for the Quarter ended March 31, 2020 View   PDF
Feb 24, 2020Board Meeting for the Year ended December 31, 2019 View   PDF
Nov 15, 2019Board of Directors' meeting Other than Financial results View   PDF
Nov 14, 2019Board Meeting in Progress View   PDF
Nov 6, 2019Board Meeting Other than Financial Results View   PDF
DateTitleDocument
Oct 13, 2020Corporate Briefing Session for the year 2020 View   PDF
Aug 17, 2020Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Jun 8, 2020Credit of Final Cash Dividend for the Year 2019 View   PDF
May 20, 2020Election of Directors View   PDF
May 11, 2020Notice for Election of Directors u/s 159(4) of the Companies Act, 2017 View   PDF
Mar 30, 2020sanofi-aventis Pakistan Limited - Notice of postponement of AGM View   PDF
Nov 13, 2019Corporate Briefing Session for the year 2019 View   PDF
Oct 30, 2019Transmission of Financial Statements for nine months Ended September 30, 2019 View   PDF
May 7, 2019Credit of Final Cash Dividend View   PDF
Apr 24, 2019Change of Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales14,500,67812,960,83912,446,05211,890,235
Profit after Taxation154,836612,7921,006,1211,018,922
EPS16.0563.54104.32105.65
Q3 2020Q2 2020Q1 2020Q3 2019
Sales4,060,7943,195,3613,421,0683,658,512
Profit after Taxation97,032(18,772)(84,413)19,488
EPS10.06(1.95)(8.75)2.02
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)25.6930.4535.6433.82
Net Profit Margin (%)1.074.738.088.57
EPS Growth (%)(74.74)(39.09)(1.26)1,433.38
PEG(0.69)(0.30)(9.48)0.02

Payouts

DateFinancial ResultsDetailsBook Closure
March 3, 2020 3:51 PM31/12/2019(YR) 80% (D) 13/05/2020 - 20/05/2020
March 1, 2019 1:38 PM31/12/2018(YR) 300% (F) (D) 17/04/2019 - 23/04/2019
March 7, 2018 3:01 PM31/12/2017(YR) 450% (D) 20/04/2018 - 26/04/2018
March 8, 2017 12:53 PM31/12/2016(YR) 300% (D) 19/04/2017 - 25/04/2017
February 25, 2016 10:14 AM31/12/2015(YR) 30% (D) 19/04/2016 - 25/04/2016
March 12, 2015 1:37 PM31/12/2014(YR) 70% (D) 21/04/2015 - 27/04/2015
February 26, 2014 2:19 PM31/12/2013(YR) 100% (D) 18/04/2014 - 25/04/2014
February 28, 2013 10:15 AM31/12/2012(YR) 125% (F) (D) 19/04/2013 - 25/04/2013
February 22, 2012 2:29 PM31/12/2011(YR) 100%(F) (D) 18/04/2012 - 24/04/2012
February 14, 2011 9:52 AM31/12/2010(YR) 100%(F) (D) 23/03/2011 - 29/03/2011

Financial Reports